Antiplatelet Drugs: Mechanisms and Risks of Bleeding Following Cardiac Operations
We hypothesize that review of available evidence regarding drug-related bleeding risk, underlying mechanisms of platelet dysfunction, and variations in patient response to antiplatelet drugs will aid surgeons as they assess preoperative risk and attempt to limit perioperative bleeding.
Peripheral Extracorporeal Membrane Oxygenation System as Salvage Treatment of Patients with Refractory Cardiogenic Shock: Preliminary Outcome Evaluation
The novel Permanent Life Support (PLS; Maquet, Jostra Medizintechnik AG, Hirrlingen, Germany) as peripheral veno-arterial extracorporeal membrane oxygenation (ECMO) support system has been investigated as treatment for patients with refractory cardiogenic shock (CS).
Increasing Duration of Circulatory Arrest, but not Antegrade Cerebral Perfusion, Prolongs Postoperative Recovery after Neonatal Cardiac Surgery
Therefore, in this study, the impact of duration of DHCA and ACP on postoperative recovery was analyzed in a cohort of neonates undergoing aortic arch reconstruction.
Nafamostat Mesilate, As a Treatment for Heparin Resistance, Is not Associated with Perioperative Ischemic Stroke in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
No evidence was found that nafamostat mesilate was associated with perioperative ischemic stroke in heparin-resistant patients undergoing cardiac surgery with cardiopulmonary bypass.
Institution of Extracorporeal Membrane Oxygenation Late after Lung Transplantation – A Futile Exercise?
Late institution of ECMO in lung transplant recipients for causes other than primary graft failure is associated with such poor survival that its use should be considered only in very select cases.
First Experience with the New Portable Extracorporeal Membrane Oxygenation System Cardiohelp for Severe Respiratory Failure in Adults
In this report, we present our early experience with the Cardiohelp, a new portable miniaturized ECMO system, in 22 consecutive patients with ARDS.
Weaning from Venovenous Extracorporeal Membrane Oxygenation without Anticoagulation: Is it Possible?
Based on this single experience, management and weaning without any anticoagulant agent might be possible.
Extracorporeal Membrane Oxygenation in Maternal Arrhythmic Cardiogenic Shock
We report the first case of the use of ECMO for the treatment of cardiac arrhythmia with cardiogenic shock in a pregnant woman.
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Severe Respiratory Failure in Japan
To evaluate procedures and outcomes of extracorporeal membrane oxygenation (ECMO) therapy applied to 2009 influenza A(H1N1) severe respiratory failure patients in Japan.
Outcome of Patients with Profound Cardiogenic Shock after Cardiopulmonary Resuscitation and Prompt Extracorporeal Membrane Oxygenation Support. A Single-Center Observational Study
Profound CS was associated with high mortality. Both successful weaning from ECMO and an APACHE II score might serve as outcome predictors for risk stratification.
Short-Term Independent Mortality Risk Factors in Patients with Cirrhosis Undergoing Cardiac Surgery
We conclude that central venous pressure could be a valuable predictor of short-term outcome in patients with cirrhosis undergoing cardiac surgery. The model for end-stage liver disease score is the best predictor of cirrhotic patients who are at high risk for cardiac surgery.
Transplantation of Engineered Heart Tissue as a Biological Cardiac Assist Device for Treatment of Dilated Cardiomyopathy
The aim of this study was to characterize an alternative treatment for dilated cardiomyopathy (DCM) using a novel cardiac biological assist device created from engineered heart tissue (EHT).